◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

H.U. Group Holdings, Inc. (4544) Financial History

Name: H.U. Group Holdings, Inc. (4544) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-08-11

H.U. Group Holdings, Inc. (4544) operates in the Diagnostics & Research industry and is headquartered in Tokyo, Japan with about 5,157 employees. Its market capitalization is roughly JPY 194 billion. In the fiscal year ended 2026-03-31, 4544 reported JPY 247.4B in revenue and JPY 6.8B in net income.

H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally.

Interactive charts & full statements →

4544 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 247.4B	JPY 243.0B	JPY 236.9B	JPY 260.9B
Gross Profit	JPY 71.4B	JPY 67.2B	JPY 63.2B	JPY 89.9B
Operating Income (EBIT)	JPY 4.8B	JPY 2.6B	(JPY 4.0B)	JPY 23.4B
Net Income	JPY 6.8B	JPY 2.8B	(JPY 7.6B)	JPY 15.7B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4544 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 7.1B)	(JPY 7.1B)	(JPY 7.1B)	(JPY 7.1B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4544 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Total Assets	JPY 267.5B	JPY 279.6B	JPY 290.8B	JPY 297.9B	—
Total Liabilities	JPY 130.0B	JPY 142.3B	JPY 148.3B	JPY 147.9B	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4544 viewer.

4544 Metric Deep Dives

Other Companies in Diagnostics & Research

2359 · WuXi AppTec Co., Ltd. — $594 billion
4694 · BML, Inc. — $134 billion
2268 · WuXi XDC Cayman Inc. — $81 billion
2395 · Shin Nippon Biomedical Laboratories, Ltd. — $62 billion
LONN · Lonza Group AG — $39 billion
3347 · Hangzhou Tigermed Consulting Co., Ltd — $35 billion
4671 · FALCO HOLDINGS Co., Ltd. — $27 billion
6127 · Joinn Laboratories(China)Co.,Ltd. — $21 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4543 All “0-9” companies 4547 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.